IOVANCE BIOTHERAPEUTICS, INC. Variable Lease, Cost
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Variable Lease, Cost of $421.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-06
- IOVANCE BIOTHERAPEUTICS, INC. variable lease, cost for the quarter ending 2026-06-30 was $421.00K, a 34.12% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. variable lease, cost for the quarter ending 2026-03-31 was $508.00K, a 46.07% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. variable lease, cost for the quarter ending 2025-12-31 was $515.00K, a 32.41% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. variable lease, cost for the quarter ending 2025-09-30 was $526.00K, a 0.57% increase year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. variable lease, cost for fiscal 2025 was $2.62M, a 34.37% decline from fiscal 2024.
- IOVANCE BIOTHERAPEUTICS, INC. variable lease, cost for fiscal 2024 was $4.00M, a 47.63% decline from fiscal 2023.
- IOVANCE BIOTHERAPEUTICS, INC. variable lease, cost for fiscal 2023 was $7.63M, a 40.06% increase from fiscal 2022.
- IOVANCE BIOTHERAPEUTICS, INC. variable lease, cost for fiscal 2022 was $5.45M, a 17.16% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $421.00K 10-Q · filed 2026-08-06 | $929.00K 10-Q · filed 2026-08-06 | $1.44M derived: sum of 3 quarters · filed 2026-08-06 | $1.97M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $508.00K 10-Q · filed 2026-05-07 | $1.02M derived: sum of 2 quarters · filed 2026-05-07 | $1.55M derived: sum of 3 quarters · filed 2026-05-07 | $2.19M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $515.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.04M derived: sum of 2 quarters · filed 2026-02-24 | $1.68M derived: sum of 3 quarters · filed 2026-08-06 | $2.62M 10-K · filed 2026-02-24 |
| 2025-09-30 | $526.00K 10-Q · filed 2025-11-06 | $1.17M derived: sum of 2 quarters · filed 2026-08-06 | $2.11M 10-Q · filed 2025-11-06 | $2.87M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $639.00K 10-Q · filed 2026-08-06 | $1.58M 10-Q · filed 2026-08-06 | $2.34M derived: sum of 3 quarters · filed 2026-08-06 | $2.87M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $942.00K 10-Q · filed 2026-05-07 | $1.70M derived: sum of 2 quarters · filed 2026-05-07 | $2.23M derived: sum of 3 quarters · filed 2026-05-07 | $3.33M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $762.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.28M derived: sum of 2 quarters · filed 2026-02-24 | $2.39M derived: sum of 3 quarters · filed 2026-02-24 | $4.00M 10-K · filed 2026-02-24 |
| 2024-09-30 | $523.00K 10-Q · filed 2025-11-06 | $1.63M derived: sum of 2 quarters · filed 2025-11-06 | $3.23M 10-Q · filed 2025-11-06 | $5.13M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $1.10M 10-Q · filed 2025-08-07 | $2.71M 10-Q · filed 2025-08-07 | $4.61M derived: sum of 3 quarters · filed 2025-08-07 | $6.34M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $1.61M 10-Q · filed 2025-05-08 | $3.51M derived: sum of 2 quarters · filed 2025-05-08 | $5.24M derived: sum of 3 quarters · filed 2025-05-08 | $7.54M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $3.63M derived: sum of 2 quarters · filed 2025-02-27 | $5.93M derived: sum of 3 quarters · filed 2025-02-27 | $7.63M 10-K · filed 2025-02-27 |
| 2023-09-30 | $1.73M 10-Q · filed 2024-11-07 | $4.04M derived: sum of 2 quarters · filed 2024-11-07 | $5.73M 10-Q · filed 2024-11-07 | $7.30M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $2.31M 10-Q · filed 2024-08-08 | $4.00M 10-Q · filed 2024-08-08 | $5.57M derived: sum of 3 quarters · filed 2024-08-08 | $7.23M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $1.69M 10-Q · filed 2024-05-09 | $3.26M derived: sum of 2 quarters · filed 2024-05-09 | $4.92M derived: sum of 3 quarters · filed 2024-05-09 | $6.16M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $1.56M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $3.23M derived: sum of 2 quarters · filed 2024-02-28 | $4.47M derived: sum of 3 quarters · filed 2024-02-28 | $5.45M 10-K · filed 2024-02-28 |
| 2022-09-30 | $1.67M 10-Q · filed 2023-11-07 | $2.90M derived: sum of 2 quarters · filed 2023-11-07 | $3.88M 10-Q · filed 2023-11-07 | $4.76M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $1.24M 10-Q · filed 2023-08-08 | $2.22M 10-Q · filed 2023-08-08 | $3.09M derived: sum of 3 quarters · filed 2023-08-08 | $4.58M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $980.00K 10-Q · filed 2023-05-10 | $1.86M derived: sum of 2 quarters · filed 2023-05-10 | $3.34M derived: sum of 3 quarters · filed 2023-05-10 | $4.92M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $877.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $2.36M derived: sum of 2 quarters · filed 2023-02-28 | $3.94M derived: sum of 3 quarters · filed 2023-02-28 | $4.65M 10-K · filed 2023-02-28 |
| 2021-09-30 | $1.48M 10-Q · filed 2022-11-03 | $3.06M derived: sum of 2 quarters · filed 2022-11-03 | $3.77M 10-Q · filed 2022-11-03 | $5.02M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $1.58M 10-Q · filed 2022-08-04 | $2.29M 10-Q · filed 2022-08-04 | $3.54M derived: sum of 3 quarters · filed 2022-08-04 | $5.24M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $710.00K 10-Q · filed 2022-05-05 | $1.96M derived: sum of 2 quarters · filed 2022-05-05 | $3.66M derived: sum of 3 quarters · filed 2022-05-05 | $4.92M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $2.95M derived: sum of 2 quarters · filed 2022-02-24 | $4.21M derived: sum of 3 quarters · filed 2022-02-24 | $5.58M 10-K · filed 2022-02-24 |
| 2020-09-30 | $1.70M 10-Q · filed 2021-11-04 | $2.96M derived: sum of 2 quarters · filed 2021-11-04 | $4.33M 10-Q · filed 2021-11-04 | $6.23M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $1.26M 10-Q · filed 2021-08-05 | $2.63M 10-Q · filed 2021-08-05 | $4.52M derived: sum of 3 quarters · filed 2021-08-05 | $6.49M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $1.37M 10-Q · filed 2021-05-06 | $3.26M derived: sum of 2 quarters · filed 2021-05-06 | $5.23M derived: sum of 3 quarters · filed 2021-05-06 | $6.28M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $3.86M derived: sum of 2 quarters · filed 2021-02-25 | $4.91M derived: sum of 3 quarters · filed 2021-02-25 | $5.80M 10-K · filed 2021-02-25 |
| 2019-09-30 | $1.97M 10-Q · filed 2020-11-05 | $3.01M derived: sum of 2 quarters · filed 2020-11-05 | $3.91M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $1.04M 10-Q · filed 2020-08-06 | $1.94M 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $896.00K 10-Q · filed 2020-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |